Overview

A Pharmacokinetics Study of Intravenous Ascorbic Acid

Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
This is a Phase 1, single-dose study to evaluate the pharmacokinetics of intravenous Ascorbic Acid.
Phase:
Phase 1
Details
Lead Sponsor:
McGuff Pharmaceuticals, Inc.
Treatments:
Ascorbic Acid